Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04898634 |
|---|---|
| Brief Title: | A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer |
| First Submitted : | May 20, 2021 |
| First Submitted that Met QC Criteria : | May 20, 2021 |
| First Posted : | May 24, 2021 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |